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Is wearing of elastic stockings for half a day as 
effective as wearing them for the entire day?
The aim of this work was to evaluate whether the use of 
compression stockings during part of the day would help in 
the reduction of evening oedema in patients with Clinical, 
Epidemiological, Anatomical and Physiopathological 
classifications 0 and 1. Volumetry using the water dis-
placement technique was performed in the morning and 
in the evening. When the patients wore the stockings only 
during the morning, volumetry was also performed at 
13:00 h. Significant increases in volume were observed for 
both legs when stockings were not used compared with 
the use of stockings in the morning only. After removing 
the stockings, both legs had significant increases in vol-
ume in the afternoon. However, use for half of the day was 
better than not using the stockings at all. Br J Dermatol 
2010; 162:42–5.
Iontophoretic terbinafine delivery  
in onychomycosis: a preliminary study
This study aimed to evaluate the efficacy, safety and 
tolerability of topical treatments with terbinafine HCl deliv-
ered with or without an iontophoretic patch in patients 
with onychomycosis of the toenails. A significant clinical 
response was recorded in patients treated with terbinafine 
under a constant current density of 100 µA cm–2 (active 
group). The percentage of patients having healthy toenail 
growth of more than 1.5 mm at the end of treatment was 
40% compared with 11% in patients treated with terbin-
afine without current (passive group). The percentage of 
patients having fungal elements (KOH) in nail specimens 
decreased significantly at 8 weeks following the comple-
tion of treatment: 16% in the active group vs. 53% in the 
passive group. Br J Dermatol 2010; 162:46–50.
Clinical predictors of leg ulcer healing
Moffatt et al. aimed to determine factors associated with 
healing in patients with chronic leg ulceration of all types 
within a defined patient population in the U.K. In total, 
113 patients took part in this study. Univariate analysis 
revealed statistically significant differences for delayed 
healing according to the ulcer duration (P = 0.002), 
complexity of the ulcer aetiology (P = 0.035), pres-
ence of lipoderm atosclerosis (P = 0.02), history of deep 
vein thrombosis (DVT) (P = 0.03) and thrombophlebitis 
(P = 0.03). Multivariate analysis showed that ulcer duration 
(P = 0.014), DVT (P = 0.008) and a lack of Pseudomonas 
on wound swab (P = 0.005) were independently associ-
ated with delayed healing. Br J Dermatol 2010; 162:51–8.
Absolute CD3+ CD158k+ lymphocyte count 
is reliable and more sensitive  
than cytomorphology to evaluate  
blood tumour burden in Sézary syndrome
CD158k⁄KIR3DL2 has previously been identified by this 
group as a new phenotypic marker for circulating Sézary cells 
in patients with Sézary syndrome (SS). In this study Bouaziz 
et al. compared the absolute CD3 + CD158k+ lympho cyte 
count with the absolute count of cyto morphological Sézary 
cells and correlated these with clinical flares in a cohort of 
patients with SS. CD3 + CD158k+ lymphocyte cell count 
was in eight cases more sensitive than cytomorphology 
for detecting atypical circulating cells especially for small-
sized tumour cells. The tumour burden evaluated by CD3 + 
CD158k+ immuno staining was significantly associated with 
clinical flare (P < 10–4). CD3 + CD158k+ phenotyping is 
concluded to be a reliable and objective test to monitor the 
blood tumour burden in patients with SS both in routine 
practice and as a response marker in therapeutic trials. Br J 
Dermatol 2010; 162:123–8.
Skin cancer: preventive photodynamic 
therapy in patients with face  
and scalp cancerization. A randomized 
placebo-controlled study
Sotiriou et al. investigated 20% aminolaevulinic acid 
(ALA)-field photodynamic therapy (PDT) as a method 
of nonmelanoma skin cancer (NMSC) prophylaxis. 
Immunocompetent patients with a history of previous 
NMSC and clinical and histological signs of field cancer-
ization on the face and scalp were included. Two selected 
areas on each patient were randomly allocated, at baseline, 
to field therapy with two treatment cycles (1 week apart) of 
ALA-PDT or placebo-PDT. Patients were reviewed at 3, 6, 
9 and 12 months and new lesions were recorded. Thirty-
nine of 45 patients completed the study. The pattern of new 
lesion development remained stable during the follow-up 
intervals for placebo-PDT, in contrast to ALA-PDT where 
it remained low for the first 6 months and then gradually 
increased, following an almost parallel course to the pla-
cebo at the end of the study period. Results suggest that 
field PDT therapy may have a role in the treatment of field 
cancerization. However, long-term follow-up studies are 
needed. Br J Dermatol 2010; 162:171–5.
